[Treatment of lupus nephritis associated with end-stage renal disease].
Approximately 10% of patients with lupus nephritis develop end-stage renal disease (ESRD). In some cases with a rapidly progressive course, treatment may result in partial recovery of renal function. The choice of aggressive treatment should be balanced against the risk of enhanced morbidity due to side effects in patients with renal insufficiency; one should therefore desist from preventing ESRD at any cost. Renal replacement therapy (both hemodialysis and peritoneal dialysis) may offer lupus patients with ESRD good chances of survival. The indications for renal replacement therapy are similar to those in other uremic patients. Systemic lupus erythematosus activity may be quenched by renal replacement therapy but it may also persist, especially during the first year. Immunosuppression and corticosteroids should be stopped when possible, as lupus patients on dialysis are liable to increased morbidity consisting of infections and cardiovascular events due to side effects of therapy. The presence of antiphospholipid antibodies may favor thrombotic events. Renal transplant offers the best rehabillitation for most lupus patients with ESRD. Many studies have reported similar patient and graft survival rates in lupus and nonlupus transplant recipients. The results are better for living-donor transplants. Patients with antiphospholipid antibodies have a higher graft failure risk. Active lupus and iatrogenic side effects are risk factors for enhanced morbidity after transplant; a 6-12 washout period before transplant is advisable for these candidates. Recurrence of lupus nephritis is a rare event which usually does not compromise the outcome of the graft.
Banfi
G
G
U.O. Nefrologia e Dialisi, Padiglione Croff, Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, IRCCS, Milano, Italy. patocroff@policlinico.mi.it
Leoni
A
A
Moroni
G
G
D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000534:rehabilitation / Q000601:surgery / Q000628:therapy*; D016030:Kidney Transplantation; D008181:Lupus Nephritis / Q000150:complications / Q000534:rehabilitation / Q000628:therapy*; D010530:Peritoneal Dialysis; D020127:Recovery of Function; D006435:Renal Dialysis; D016019:Survival Analysis; D016896:Treatment Outcome